BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv6.13.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://austechnion.com
X-WR-CALDESC:Events for 
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20200404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20201003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20210403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20211002T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20220402T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20221001T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20200625T160000
DTEND;TZID=Australia/Sydney:20200625T170000
DTSTAMP:20260913T021907
CREATED:20200611T024125Z
LAST-MODIFIED:20221023T223730Z
UID:1236-1593100800-1593104400@austechnion.com
SUMMARY:Covid-19 Impact On Business - How Do We Reinvent Ourselves?
DESCRIPTION:The COVID-19 pandemic has impacted almost every industry sector. Small\, medium and large businesses are paying a heavy price to sustain themselves during this crisis\, requiring many to reassess their business model\, services\, offerings and strategy. \nWith restrictions easing\, our business executives and government leadership is being put to the test. \nHow will we adopt to the new norm? What measures will need to be taken into account to minimise the damage to the economy and to the individuals directly affected by change? What positives can we take out of the current state? \nJoin UTS Associate Dean\, Research and Management\, Prof. Michael Blumenstein as he interviews Gabi Zodik\, Global Director at IBM and Ashod Donikian\, Founder and CEO at Navisens\, for a discussion on the challenges arising from COVID-19\, what measures their businesses are taking to transition back to the new norm\, and how it has impacted both their businesses and the industry at large. \nThis event will include a welcome message by Mr. Mark Sofer\, Israel’s Ambassador to Australia.
URL:https://austechnion.com/event/covid-19-impact-on-business-how-do-we-reinvent-ourselves/
LOCATION:ONLINE
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2020/06/UTS-Technion-banner-ad-v4.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20200707T190000
DTEND;TZID=Australia/Sydney:20200707T200000
DTSTAMP:20260913T021907
CREATED:20200611T024642Z
LAST-MODIFIED:20200619T013420Z
UID:1244-1594148400-1594152000@austechnion.com
SUMMARY:Covid-19 – are we prepared for a 2nd wave?
DESCRIPTION:With the easing of the lockdown rules\, concerns are being sounded about a possible second wave of Covid-19. The second wave of the Spanish flu pandemic in 1918-20 was particularly devastating\, as was the second wave of the Swine Flu epidemic in 2009-10. So what can be done to avoid a second wave of Covid-19? \nMore importantly\, can our hospitals cope with a second burst? How has the Covid-19 pandemic impacted the way our hospitals operate? \nDr. Shachor- Meyouhas will be moderated by Warren Bingham\, Executive Chairman\, MedTech International. \nTechnion Australia and the Australian Friends of Rambam are thrilled to welcome\, Dr. Yael Shachor- Meyouhas a Technion Alumna and Deputy Director at Rambam Hospital in Israel\, as she reveals the strategy of the leading medical centre in supporting Israel’s fight against Covid-19 and a possible second outburst.
URL:https://austechnion.com/event/covid-19-are-we-prepared-for-a-2nd-wave/
LOCATION:ONLINE
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2020/06/Yael-Shachor-banner-v4.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20200716T190000
DTEND;TZID=Australia/Sydney:20200716T200000
DTSTAMP:20260913T021907
CREATED:20200611T024424Z
LAST-MODIFIED:20200702T031430Z
UID:1240-1594926000-1594929600@austechnion.com
SUMMARY:Impacting Science from a Small Country - Q&A w Nobel Prize laureate
DESCRIPTION:Over the past two decades\, eight Israeli scientists have won the Nobel Prize\, an extraordinary achievement for a country of its size and population. \nWinning a Nobel prize is an honour that is reserved for a few extraordinary people. It is the highest recognition a scientist can achieve; it’s like winning the Oscar for best actor\, an Emmy for the best song\, or winning a Tennis grand slam. \nIn 2004\, Prof. Aaron Ciechanover and colleagues\, Prof. Avram Hershko and Prof. Irwin Rose received the prestigious Nobel prize in Chemistry for their discovery of the Ubiquitin protein. This discovery illuminates the process by which the cells of most living organisms remove unwanted proteins and it has completely transformed the way cancer and other degenerative diseases are treated. \nTechnion Australia and the Australian Academy of Science are honoured to welcome Prof. Ciechanover at our next webinar. \nIn conversation with Anna-Maria Arabia\, CEO of the Australian Academy of Science\, Ciechanover will discuss the future of medicine and cancer research\, talk about Israel’s unique entrepreneurial ecosystem and how it impacts global research\, and share from his journey to winning a Nobel prize.
URL:https://austechnion.com/event/impacting-science-from-a-small-country-qa-w-nobel-prize-laureate/
LOCATION:Victoria
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2020/06/Ciechanover-banner_v2.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20200806T190000
DTEND;TZID=Australia/Sydney:20200806T203000
DTSTAMP:20260913T021907
CREATED:20200722T040747Z
LAST-MODIFIED:20200727T100808Z
UID:1347-1596740400-1596745800@austechnion.com
SUMMARY:Technology Empowering Disability
DESCRIPTION:Dr. Amit Goffer experienced a tragic accident that confined him to a wheelchair – as an accomplished inventor and entrepreneur\, he didn’t accept his fate to never stand up right again and immediately started to develop alternative modes of transport to the traditional wheelchair. \nIn 2001 he created the ReWalk system\, the first commercially available exoskeleton. Due to the severity of his injury\, Amit couldn’t use it himself\, but hundreds of thousands of people could benefit from it. (Amit is a quadriplegic – ReWalk is designed for paraplegics). \nMore recently\, he developed UPnRIDE to provide full mobility in a standing position in almost any urban environment. That is something that Amit\, as a quadriplegic\, has benefited from. \nTechnion Australia and the University of Melbourne are delighted to welcome Amit at our next webinar which will also include Jim Patrick AO\, VP and Chief Scientist Emeritus at Cochlear. Cochlear is among Australia’s most iconic brands and has given deaf people the gift of hearing for almost 40 years. Cochlear designs\, manufactures and distributes innovative hearing implants. \nJim has been involved in Cochlear implant research and commercial development since 1975\, when he joined Cochlear Founder\, Greame Clark’s research team. In 1981 he moved to Sydney as a member of the Cochlear “Tiger Team” inside the Nucleus group\, developing a ‘clinically applicable’ Cochlear implant. He has been a member of Cochlear’s leadership team having at different times responsibility for R&D\, Clinical Research and Manufacturing. Jim is considered a world authority on Cochlear implants. \nAmit and Jim will discuss the power that technology has to overcome disability\, the future of biomedical engineering and how to create an innovative culture.
URL:https://austechnion.com/event/technology-empowering-disability/
LOCATION:ONLINE
CATEGORIES:Technion Australia
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2020/07/600x400of-TA-MoU-banner.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20201110T180000
DTEND;TZID=Australia/Sydney:20201110T190000
DTSTAMP:20260913T021907
CREATED:20201103T030639Z
LAST-MODIFIED:20201103T030639Z
UID:1433-1605031200-1605034800@austechnion.com
SUMMARY:The Future of MedTech in a Covid World
DESCRIPTION:The COVID-19 pandemic has had a significant impact around the world. Unforeseen challenges have forced industries everywhere to innovate like never before. \nThe Med-Tech industry is no exception. In addition to increasing manufacturing capacity and capabilities\, innovators and industry leaders have had to look outside standard medical and health sectors to explore creative solutions and support public-health needs. \nLearn how some of the world’s best Med-Tech innovators from Australia and Israel have embraced this challenge by registering for ‘The Future of Med-Tech in a COVID World’ on Tuesday 10 November at 6:00pm (AEDT) / 9:00am (Israel). \nOur dynamic panel will discuss where they see trends and changes in the global MedTech ecosystem and what the future holds for MedTech in a COVID world. \nMeet the panel: \n\nGreg Peake – SVP Innovation at ResMed\nProfessor Alon Wolf – VP External Relations & Resources Development and Head\, Biorobotics and Biomechanics Lab\, Technion – Israel Institute of Technology\nDina Titkova (moderator) – Health 10x Program Manager\, UNSW Founders\n\nYou can learn more about our panellists and what they will be discussing here.
URL:https://austechnion.com/event/the-future-of-medtech-in-a-covid-world/
LOCATION:ONLINE
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2020/11/Wolf_Peake-banner-new.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20201118T190000
DTEND;TZID=Australia/Sydney:20201118T200000
DTSTAMP:20260913T021907
CREATED:20201103T025900Z
LAST-MODIFIED:20201103T025900Z
UID:1425-1605726000-1605729600@austechnion.com
SUMMARY:Shaping Your Entrepreneurial Path - Industry Insights into StartUps and Venture Capital
DESCRIPTION:Technion Australia and the Australian National University Alumni Team are delighted to invite you to a conversation with three influential leaders who will share the do’s and don’ts of starting your own business\, what you need to do to be noticed by investors and venture capitals\, why more women in STEM is key to creating a stronger and more sustainable society\, how COVID impacted the startup ecosystem\, as well as learning from Israel – the StartUp Nation\, which produces more Startups and entrepreneurs than anywhere else. \nSpeakers: \nJulia Kagan  \nTechnion – Israel Institute of Technology alumna\, Julia Kagan is a Principal at the Jerusalem Venture Partners (JVP)\, among the worlds leading venture capital firms which specialises in investments in startup companies\, focusing on Digital Media\, Enterprise Software\, Semiconductors\, Storage and Cyber Security\, having raised close to 1.4 billion US Dollars across nine funds. JVP is headquartered in Jerusalem\, Israel with offices in Be’er Sheva\, New York City and Paris. Prior to her role with JVP\, Julia was the Business Development Manager of Leidos Israel and part of the executive team responsible for establishing Lockheed Martin IT operations in Israel. prior to that she spent six years in the elite Computer Security and Intelligence (C4I) unit at the Israeli Defence Forces as a Captain (res.) Julia holds an MBA from Tel Aviv University\, and a B.Sc. in Industrial Engineering and Management from the Technion\, graduating both magna cum laude. Within her role at JVP\, she supports the partners in the investment process and works closely with companies post-investment. \nSophia Hamblin Wang  \nANU alumna\, Sophia Hambin Wang (BIntBus (Hons) ’09) is the current Chief Operating Officer of Mineral Carbonation International (MCi)\, an Australian based research engineering company focused on developing and commercialising technologies for large scale CO2 storage through mineral carbonation. She is a carbon utilisation technologist\, circular economy specialist\, science and business communicator\, University of Sydney Business School Lecturer and member of the ACT Climate Change Council. She has featured in The New York Times\, TIME Magazine\, ABC TV’s Q&A\, The Australian\, The World Economic Forum Annual Meeting and ABC Radio in 2020. \nModerator:Anna-Maria Arabia \nAnna-Maria\, is the CEO of the Australian Academy of Science. Prior to that she was a Principal Adviser to the Hon Bill Shorten\, the past leader of the opposition. Previously\, she was also a General Manager at Questacon – the National Science and Technology Centre; and CEO of Science & Technology Australia. \nAnna-Maria will moderate the discussion and take questions from the audience.  \n* By registering to this webinar you agree to let ANU use your email address for the purposes of event registration and to receive information about similar programming\, news and events
URL:https://austechnion.com/event/shaping-your-entrepreneurial-path-industry-insights-into-startups-and-venture-capital/
LOCATION:ONLINE
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2020/11/Kagan_Wang-b_w-banner_v3.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20201126T190000
DTEND;TZID=Australia/Sydney:20201126T200000
DTSTAMP:20260913T021907
CREATED:20201103T030144Z
LAST-MODIFIED:20201104T025112Z
UID:1429-1606417200-1606420800@austechnion.com
SUMMARY:Quantum Mechanics and the Future of Computing – So What's all the Fuss About?
DESCRIPTION:What Quantum Science actually means? how will it affect our daily lives and impact health\, environment and security.
URL:https://austechnion.com/event/the-future-is-in-the-quantum/
LOCATION:ONLINE
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2020/11/Kaminer_Eagglton-banner-1.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20210204T200000
DTEND;TZID=Australia/Sydney:20210204T210000
DTSTAMP:20260913T021907
CREATED:20210119T011109Z
LAST-MODIFIED:20210119T011109Z
UID:1497-1612468800-1612472400@austechnion.com
SUMMARY:HOW SCREEN TIME AFFECTS KID’S BRAIN DEVELOPMENT
DESCRIPTION:We all know that too much time in front of a screen has health and well-being implications\, including\, social\, emotional\, cognitive\, and physical aspects. But how does too much screen time actually affect our children’s brain development\, what is even considered “too much” and how do we manage it effectively?  \nWe are thrilled to welcome Dr. Tzipi Horowitz-Kraus from the Technion. Tzipi is an Assistant Professor and the Director of the Educational Neuroimaging Center in the Faculty of Education in Science and Technology and at the Faculty of Biomedical Engineering at the Technion – Israel Institute of Technology. She is also an Associate Professor of Paediatrics and Neuroscience and the Scientific Director of the Reading and Literacy Discovery Center at Cincinnati Children’s Hospital Medical Center\, Ohio\, USA.
URL:https://austechnion.com/event/how-screen-time-affects-kids-brain-development/
LOCATION:ONLINE
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2021/01/Tzipi-Horowitz-banner.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20210411T193000
DTEND;TZID=Australia/Sydney:20210411T203000
DTSTAMP:20260913T021907
CREATED:20210325T034640Z
LAST-MODIFIED:20210325T034658Z
UID:1593-1618169400-1618173000@austechnion.com
SUMMARY:A view into a mental health brain during Covid-19 times
DESCRIPTION:Our speakers: \nProf. Ian Hickie AM\, University of Sydney \nProf. Hickie is Co-Director\, Health and Policy at The University of Sydney’s Brain and Mind Centre. He is an NHMRC Senior Principal Research Fellow (2013-2017 and 2018-22)\, having previously been one of the inaugural NHMRC Australian Fellows (2008-12). He was an inaugural Commissioner on Australia’s National Mental Health Commission (2012-18) overseeing enhanced accountability for mental health reform and suicide prevention. He is an internationally renowned researcher in clinical psychiatry\, with particular reference to medical aspects of common mood disorders\, depression and bipolar disorder. He is now focused on the development of real-time personalized and measurement-based care systems for use in partnership with young people and their families. These systems promote early intervention\, use of new and emerging technologies and suicide prevention. In his role with the National Mental Health Commission\, and his independent research\, health system and advocacy roles\, Prof. Hickie has been at the forefront of the move to have mental health and suicide prevention integrated with other aspects of health care (notably chronic disease and ambulatory care management). \nProf. (Eme) Dorit Ben Shachar\, Technion – Israel Institiute of Technology  \nProf. Ben-Shachar\,PhD is the Head\, Laboratory of Psychobiology\, Department of Psychiatry\, at The Ruth and Bruce Rappaport Faculty of Medicine\, Rambam Health Care Campus\, Technion – Israel Institute of Technology.Her research interests include\, Mitochondrial abnormalities in schizophrenia at the level of RNA and protein modulations\, ECT activity\, mitochondrial respiration and network dynamics. \nHer lab focus in Nano Field: using Nano based technologies as NGS\, GWAS as well as Confocal and time lapse microscopy. \nModerator: Dr. Norman Swan\, physician and journalist \nProducer and presenter of the Health Report\, Dr. Swan\, is a multi-award winning producer and broadcaster. \nDr Swan’s career has been highlighted by his desire to keep the Australian public informed of health developments as they happen. This allows him to combine medical expertise with investigative reporting\, clear analysis and the knowledge to report the latest research in health and medicine. \nOne of the first medically qualified journalists in Australia\, Dr Swan is highly regarded by the medical and health professions. \nEvent partners
URL:https://austechnion.com/event/a-view-into-a-mental-health-brain-during-covid-19-times/
LOCATION:Victoria
CATEGORIES:Technion Australia
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2021/03/Banner_v3.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20210527T173000
DTEND;TZID=Australia/Sydney:20210527T183000
DTSTAMP:20260913T021907
CREATED:20210506T001242Z
LAST-MODIFIED:20210506T001242Z
UID:1603-1622136600-1622140200@austechnion.com
SUMMARY:Exploring the Dark Web - Cybercrime and Cyber Security in the Digital Age
DESCRIPTION:Technological breakthroughs have enabled humanity to advance in a pace and manner that only a few decades ago would not have been imagined.  \nIronically this brings with it some of the greatest challenges we also face today.  \nFrom countries\, states and large economies\, through to private or public companies\, not-for-profit organisations\, down to individuals like you\, are all exposed to an ever increasing technological threat – Cyber related threats.  \nMost organisations\, irrespective of size gather an enormous amount of information and corporate intellectual property. Often the information they have is very sensitive making it a target for attacks which are generally aimed at gathering information\, harming information\, or disabling services. Such attacks can damage an organisation’s reputation\, endanger virtual and physical assets which result in significant financial costs. Cyber attacks on government and public bodies and infrastructure may disrupt the lives of an entire state and even compromise the wellbeing and security of its citizens.  \nOur presenters are at the forefront of cyber security intelligence and the insights they share will enable attendees to underestand these problems and offer possible solutions.  \nSpeakers: \nJasmina Zito \nJasmina is a security engineer who specialises in Cyber Threat Intelligence; as well as a freelance illustration artist. She started her career in video game development and Japanese fashion before shifting to cyber security. She now works at Canva in the detection and response team\, keeping Canvanauts and Canva users safe from cyber baddies. \nJasmina holds a Bachelor’s Degree\, Science in Games Development\, Network Security from the University of Technology\, Sydney. \n\n\nAvi Kasztan \n\nAvi brings more than 20 years of entrepreneurial and leadership experience in the technology and network security industry. He is the Founder of Sixgill\, a leading Israeli Cyber Intelligence company in the DarkWeb arena \nPrior to Sixgill\, Avi served at key roles in legendary disruptive companies at their earliest stages such as Checkpoint (creators of first software firewall that uses stateful inspection)\, and Vocaltec (creators of first VOIP).  \nAvi holds a BSc. In Computer Engineering and MBA in management of Hi Tech firms\, both degrees from the Technion – Israel Institue of Technology. \nThe event will be moderated by Prof. Michael Blumenstein\, Associate Dean (Research Strategy and Management) at University of Technology Sydney \n.
URL:https://austechnion.com/event/exploring-the-dark-web-cybercrime-and-cyber-security-in-the-digital-age/
LOCATION:ONLINE
CATEGORIES:Technion Australia
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2021/05/Avi-and-Jasmina-Eventbrite-banner.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20210811T180000
DTEND;TZID=Australia/Sydney:20210811T193000
DTSTAMP:20260913T021907
CREATED:20210728T013144Z
LAST-MODIFIED:20210728T013144Z
UID:1703-1628704800-1628710200@austechnion.com
SUMMARY:The Sky is NOT the Limit
DESCRIPTION:The so called “space race” between the world’s most powerful economies (mostly the U.S.\, Russia and China) is no longer restricted to governments. \nRecently\, Billionaire Jeff Bezos spent 10 minutes in space in his ‘New Shepard’ spaceship\, a few days earlier Richard Branson was also “touring” space and it is all happening while Elon Musk is working on his “out of this world” project to inhabit Mars – Space X. \nAustralia and Israel are not staying behind. They are investing substantially to join the “race”. \nNext year\, Eytan Stibbe will become the second Israeli to enter space. Eytan will conduct several experiments that are expected to advance the study of science and medicine in Israel in various fields. Three of these experiments\, from the Technion will be launched to the International Space Station. \nFurthermore\, a group of three autonomous microsatellites developed by the Technion were launched into space. The trio – part of the Adelis-SAMSON project – will be able to calculate the location of radiating sources on Earth\, locating people\, airplanes\, and marine vessels\, thus enabling search-and-rescue missions around the world. \nMeanwhile\, the Australian Space Agency approves plan to launch test rockets from Whalers Way near Port Lincoln\, which follows the Australian Government’s recent announcement of helping local space manufacturers expand their supply chains globally through its AU$1.3 billion Modern Manufacturing Initiative. \nJoin global space experts as they share insight into the future of space\, how it affects everyday life and what role Australia and Israel play in this world.
URL:https://austechnion.com/event/the-sky-is-not-the-limit/
LOCATION:ONLINE
CATEGORIES:Technion Australia
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2021/07/Speakers.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20210919T190000
DTEND;TZID=Australia/Sydney:20210919T200000
DTSTAMP:20260913T021907
CREATED:20210912T215257Z
LAST-MODIFIED:20210912T215316Z
UID:1790-1632078000-1632081600@austechnion.com
SUMMARY:ASK THE EXPERT - COVID-19
DESCRIPTION:Hear from infectious disease expert on Israel’s and Australia’s Covid-19 strategy and challenges.\n\n\n\n\n\nAbout this event\n\n\nWith having reached over 1\,000 positive cases of COVID-19 a day\, many parts of Sydney and NSW have been in strict lockdown for over two months now. In the rest of Australia the figures are even lower\, yet most parts are also experiencing continued lockdown. On the flip side\, Israel which has a similar population count to NSW\, is enjoying much greater freedom despite reaching the highest peak during the entire pandemic of over 10\,000 positive cases of Covid-19 a day. \nHow can that be explained?
URL:https://austechnion.com/event/1790/
LOCATION:Victoria
ATTACH;FMTTYPE=image/png:https://austechnion.com/wp-content/uploads/2021/09/Michael-Wallach-invite.png
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20220120T190000
DTEND;TZID=Australia/Sydney:20220120T200000
DTSTAMP:20260913T021907
CREATED:20220114T032606Z
LAST-MODIFIED:20220120T065956Z
UID:1854-1642705200-1642708800@austechnion.com
SUMMARY:Variants\, Boosters and Big Data
DESCRIPTION:Researchers are uncovering new insights about COVID-19 seemingly every day — but what does that mean for us\, our loved ones\, and our communities as we enter the third year of this pandemic? \nJoin Associate Professor Yair Goldberg and Assistant Professor Dvir Aran\, for this fascinating briefing on where things stand with the novel coronavirus\, virus variants like Delta and Omicron\, and the efficacy of booster shots. Panelists will also share updates from COVID-19 research they are currently conducting\, and what it might mean for future detection\, treatment\, and prevention efforts. \nOpening comments and moderation by Dr. Ruth Ratner\, GP\, Technion Australia’s President. \nYair Goldberg is an associate professor of statistics in the Faculty of Industrial Engineering and Management at the Technion and the Vice Dean for Graduate Studies. His lab uses statistical and machine learning tools to address theoretical questions and real-world problems. Recent papers have focused on both the protection against COVID-19 provided by the Pfizer vaccine and its waning immunity in Israel. In the past two years\, he has been part of a research team advising Israel’s Ministry of Health on COVID-19 policymaking. Prof. Goldberg earned his Ph.D. from the Hebrew University of Jerusalem. He conducted postdoctoral research at the Department of Biostatistics and was a statistical consultant for The Translational and Clinical Science Institute — both at the University of North Carolina\, Chapel Hill\, and then a faculty member at the University of Haifa\, before joining the Technion faculty in 2018. \nDvir Aran is an assistant professor at the Faculty of Biology and the Henry and Marilyn Taub Faculty of Computer Science at the Technion. His research field is computational biology\, using data science and AI to advance biological and medical research. He develops computational tools and applies them to integrate and analyze big data from multiple sources\, including genomic and epigenetic data and electronic medical records. His research aims to advance the understanding of the tumor microenvironment\, as well as the immune system\, and their relationship with potential treatments. Prof. Aran has gained international recognition for his contributions to the understanding of the tumor microenvironment and other diseases. Since the COVID-19 outbreak began\, Prof. Aran has been conducting modeling and analyses of real-world publicly-available COVID-19 data to understand early indications of vaccine effectiveness and waning. He was one of the first to publish research on COVID-19 vaccine effectiveness in Israel.
URL:https://austechnion.com/event/variants-boosters-and-big-date/
LOCATION:ONLINE
CATEGORIES:Technion Australia
ATTACH;FMTTYPE=image/jpeg:https://austechnion.com/wp-content/uploads/2022/01/event-banner.jpg
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20220303T180000
DTEND;TZID=Australia/Sydney:20220303T190000
DTSTAMP:20260913T021907
CREATED:20220225T041944Z
LAST-MODIFIED:20220315T235149Z
UID:1894-1646330400-1646334000@austechnion.com
SUMMARY:Women and Girls Changing the World through STEMM
DESCRIPTION:You can view the recording of this webinar here: https://youtu.be/pL8iKgV_YhU \n  \nTechnion Australia is honored to host two of the world’s leaders in STEMM who changed and keep changing our world. \nJoin us to hear their personal stories and learn about their recent activities. \n \n\nProfessor Kira Radinsky – https://www.kiraradinsky.com – CEO & CTO at Diagnostic Robotics and a visiting professor at the Technion is an Israeli computer scientist\, inventor and entrepreneur\, specializing in predictive data mining. \nShe gained recognition after being selected by the MIT Technology Review to the “35 Innovators Under 35” list. Her work was described in the popular press as predicting the first in 130 years outbreak of cholera in Cuba\, based on the pattern identified by mining of 150 years of data from various sources: in poor countries\, floods within a year after a drought often follow by a cholera outbreak. \nWhile working on her Ph.D. she co-founded a company\, SalesPredict\, that was acquired by eBay Israel in 2016\, where Kira Radinsky worked as chief scientist and the director of data science during 2016–2019. \nSince 2019\, Dr. Radinsky is the Chief Executive Officer at Diagnostic Robotics\, Tel Aviv\, which she co-founded in 2017. She is also a visiting professor at Technion teaching the applications of predictive data mining in medicine. She has co-authored over 10 patents and more than 40 peer-reviewed articles. \nDr. Jenine Beekhuyzen OAM– https://www.jeninebeekhuyzen.com – Visiting Fellow at University of Technology Sydney is the creator of the Tech Girls Are Superheroes campaign. \nDr. Beekhuyzen is a futurist with international recognition for her advocacy and leadership\, her research\, and her university teaching through which she has impacted tens of thousands of students over the past 18 years. She is committed to creating a workforce capable of building the technology of the future.  \nDr Beekhuyzen is the Founder & CEO of the Tech Girls Movement Foundation and the CEO of Adroit Research. She is mobilising a tribe of next-generation leaders who are committed to solving real-world problems with technology. In the past six years at the helm of the Tech Girls Movement Foundation\, she has engaged over 10\,000 school girls in STEM entrepreneurship across more than 1000 schools. She has published over 65 internationally peer-reviewed articles in journals\, conferences and books. \n\nRegister now: https://bit.ly/IWDTA
URL:https://austechnion.com/event/women-and-girls-changing-the-world-through-stemm/
LOCATION:ONLINE
CATEGORIES:Technion Australia
ATTACH;FMTTYPE=image/jpeg:https://austechnion.com/wp-content/uploads/2022/02/banner.jpg
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20220314T190000
DTEND;TZID=Australia/Sydney:20220314T200000
DTSTAMP:20260913T021907
CREATED:20220307T120619Z
LAST-MODIFIED:20220316T005721Z
UID:1901-1647284400-1647288000@austechnion.com
SUMMARY:International Pi Day - “Lighting the way with Microscopy”
DESCRIPTION:Watch the full recording here: https://youtu.be/sO2fIGSiAE8 \n  \nTechnion Australia is pleased to invite you to  \nCelebrate International Pi Day \n  \nSpecial Free Webinar \nMonday 14 March 7-8pm Sydney/Melbourne \n  \n“Lighting the way with Microscopy” \n(A Pi special) \nPresented by \nProfessor Yoav Shechtman and Dr Onit Alalouf\n\nFrom Technion’s Nano-Bio-Optics Lab\n  \nWhat is Pi Day and why do we celebrate it? \nIt is a day to celebrate the mathematical constant pi (π) and to eat lots of pie. Pi Day celebrates the mathematical constant π (3.14). It is celebrated because the digits in the date\, March 14 or 3/14\, are the first three digits of π (3.14) \nProfessor Yoav Shechtman is Head of Technion’s Nano Bio-Optics Laboratory which has 15 members\, researchers and students\, at the Technion where he graduated with a BSc and his PhD. He undertook Post-Doctoral research at Stanford University. His research interests include: \n\nOptical super-resolution microscopy – experimental methods and algorithms\nMulti-color and three-dimensional nano-tracking\nOptical design and analysis through machine learning\nFluorescence microscopy\n\nDr Onit Alalouf\, is the Laboratory Manager and Research Associate in the Department of Biomedical Engineering at the Technion. She obtained her PhD at Technion’s Department of Biotechnology & Food Engineering\, MSc at University College\, London and BSc at the University of Hertfordshire. Dr Alalouf holds a patent in the diagnostics research area and is the recipient of a number of awards for her research. \nTo register press this button
URL:https://austechnion.com/event/international-pi-day-lighting-the-way-with-microscopy/
LOCATION:ONLINE
ATTACH;FMTTYPE=image/jpeg:https://austechnion.com/wp-content/uploads/2022/03/banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20220531T190000
DTEND;TZID=Australia/Sydney:20220531T200000
DTSTAMP:20260913T021907
CREATED:20220524T235902Z
LAST-MODIFIED:20220524T235902Z
UID:1972-1654023600-1654027200@austechnion.com
SUMMARY:Artificial Intelligence (AI) for Remote Patient Monitoring
DESCRIPTION:Special Free Webinar \nTuesday 31.5.2022- 7PM Sydney/Melbourne \n Artificial Intelligence for Remote Patient Monitoring \nConnecting the dots between Australia and Israel \nFollowing a recent collaboration agreement signed between Technion and the Ingham Institute\, come and learn how we can leverage AI to monitor and asses a patient from afar. \n  \nDr. Behar is heading the Artificial Intelligence in Medicine Laboratory (AIMLab.) at the Technion faculty of Biomedical Engineering\, Haifa\, Israel. The lab focuses on the usage of machine learning in medicine within the context of physiological time series analysis with a specific focus in cardiology\, sleep medicine and ophthalmology. Dr. Behar is also the founding director of the Technion-Rambam Center for Artificial Intelligence in Healthcare (CAIH). Dr. Behar is twice winner of the MIT-PhysioNet/Computing in Cardiology competition. He has authored and co-authored over 47 journal papers in leading engineering\, physiology and medical journals (h-index: 27) and contributed many open access databases of physiological waveform and open source code (e.g. PhysioZoo\, fecgsyn). He is the cofounder of SmartCare Analytics. He serves as editor for the journal Physiological Measurement and has been on the program committee of the Computing in Cardiology international conference since 2013. Joachim holds a PhD in biosignals processing and machine learning from the university of Oxford which was completed under the supervision of Prof. Gari D. Clifford and Dr. Julien Oster. He holds a MEng from l’Ecole Nationale Superieure des Mines de Saint-Etienne in France in Engineering. He completed his postdoctoral study in computational physiology under the guidance of Prof. Yael Yaniv at the Technion where he worked on mathematical modelling of sinoatrial node cells.
URL:https://austechnion.com/event/artificial-intelligence-ai-for-remote-patient-monitoring/
LOCATION:ONLINE
ATTACH;FMTTYPE=image/jpeg:https://austechnion.com/wp-content/uploads/2022/05/Banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20230208T183000
DTEND;TZID=Australia/Sydney:20230208T200000
DTSTAMP:20260913T021907
CREATED:20230120T042743Z
LAST-MODIFIED:20250227T063441Z
UID:2125-1675881000-1675886400@austechnion.com
SUMMARY:Melbourne - Quantum Computing - A laymen discussion with Prof. Moti Segev
DESCRIPTION:Quantum Computing: truth or hype? \n  \nOrdinary computers seem strong\, powerful\, but in fact that are very many problems that even combining all the computing power on Earth would not solve in a reasonable time (say\, 50 years). One such example is the “traveling salesman”: how to find the optimal route (the route that would take the shortest time) between 100 destinations. Another example is drug design: we know the equations governing the molecules\, but we can’t simulate their action because it is too complicated to compute with even the strongest computers. Yet another example is to break security codes within a reasonable time. But quantum computers in principle can do that. In the past decade\, we have witnessed worldwide attempts to build quantum computers. Companies do that because many of them need to optimize designs (Amazon\, IBM\, Google\, and many others). Governments do that because they want to break security codes. Pharmaceutical companies are interested because today drugs are designed through experimental “trial and error”. Is it therefore understandable why huge resources are being invested in constructing quantum computers\, and quite a few companies often hold press releases where they declare their quantum computer has demonstrated superiority to classical computers. Is all of that true or just a hype? What is the true status of quantum computing? Will we have a useful quantum computer within the next decade: a computer that can actually do something useful? Finally\, are there alternatives that can be used as interim solutions\, until one day a useful quantum computer becomes a reality? \n 
URL:https://austechnion.com/event/melbourne-quantum-computing-a-laymen-discussion-with-prof-moti-segev/
LOCATION:South Caulfield Synagogue\, 45 Leopold St\,\, Caulfield South\, Victoria\, 3162\, Australia
ATTACH;FMTTYPE=image/jpeg:https://austechnion.com/wp-content/uploads/2023/01/Melbourne-new-ad-e1740638167890.jpg
ORGANIZER;CN="Technion Australia":MAILTO:yoash.dvir@austechnion.com
END:VEVENT
END:VCALENDAR